BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

423 related articles for article (PubMed ID: 26654287)

  • 1. Clinical course of untreated cerebral cavernous malformations: a meta-analysis of individual patient data.
    Horne MA; Flemming KD; Su IC; Stapf C; Jeon JP; Li D; Maxwell SS; White P; Christianson TJ; Agid R; Cho WS; Oh CW; Wu Z; Zhang JT; Kim JE; Ter Brugge K; Willinsky R; Brown RD; Murray GD; Al-Shahi Salman R;
    Lancet Neurol; 2016 Feb; 15(2):166-173. PubMed ID: 26654287
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hemorrhage from cerebral cavernous malformations: The role of associated developmental venous anomalies.
    Chen B; Herten A; Saban D; Rauscher S; Radbruch A; Schmidt B; Zhu Y; Jabbarli R; Wrede KH; Kleinschnitz C; Sure U; Dammann P
    Neurology; 2020 Jul; 95(1):e89-e96. PubMed ID: 32513786
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Surgery for cerebral cavernous malformations: a systematic review and meta-analysis.
    Harris L; Poorthuis MHF; Grover P; Kitchen N; Al-Shahi Salman R
    Neurosurg Rev; 2022 Feb; 45(1):231-241. PubMed ID: 34191202
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Untreated clinical course of cerebral cavernous malformations: a prospective, population-based cohort study.
    Al-Shahi Salman R; Hall JM; Horne MA; Moultrie F; Josephson CB; Bhattacharya JJ; Counsell CE; Murray GD; Papanastassiou V; Ritchie V; Roberts RC; Sellar RJ; Warlow CP;
    Lancet Neurol; 2012 Mar; 11(3):217-24. PubMed ID: 22297119
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-term antithrombotic therapy and risk of intracranial haemorrhage from cerebral cavernous malformations: a population-based cohort study, systematic review, and meta-analysis.
    Zuurbier SM; Hickman CR; Tolias CS; Rinkel LA; Leyrer R; Flemming KD; Bervini D; Lanzino G; Wityk RJ; Schneble HM; Sure U; Al-Shahi Salman R;
    Lancet Neurol; 2019 Oct; 18(10):935-941. PubMed ID: 31401075
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intracranial Hemorrhage Rate and Lesion Burden in Patients With Familial Cerebral Cavernous Malformation.
    Weinsheimer S; Nelson J; Abla AA; Ko NU; Tsang C; Okoye O; Zabramski JM; Akers A; Zafar A; Mabray MC; Hart BL; Morrison L; McCulloch CE; Kim H;
    J Am Heart Assoc; 2023 Feb; 12(3):e027572. PubMed ID: 36695309
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Stereotactic radiosurgery for cerebral cavernous malformations: A systematic review.
    Poorthuis MHF; Rinkel LA; Lammy S; Al-Shahi Salman R
    Neurology; 2019 Nov; 93(21):e1971-e1979. PubMed ID: 31659093
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Radiosurgical, neurosurgical, or no intervention for cerebral cavernous malformations: A decision analysis.
    Rinkel LA; Al-Shahi Salman R; Rinkel GJ; Greving JP
    Int J Stroke; 2019 Dec; 14(9):939-945. PubMed ID: 31122172
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical course of untreated thalamic cavernous malformations: hemorrhage risk and neurological outcomes.
    Tian KB; Zheng JJ; Ma JP; Hao SY; Wang L; Zhang LW; Wu Z; Zhang JT; Li D
    J Neurosurg; 2017 Sep; 127(3):480-491. PubMed ID: 27834594
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Modifiable Cardiovascular Risk Factors in Patients With Sporadic Cerebral Cavernous Malformations: Obesity Matters.
    Chen B; Saban D; Rauscher S; Herten A; Rauschenbach L; Santos A; Li Y; Schmidt B; Zhu Y; Jabbarli R; Wrede KH; Kleinschnitz C; Sure U; Dammann P
    Stroke; 2021 Apr; 52(4):1259-1264. PubMed ID: 33588600
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Natural Course of Cerebral Cavernous Malformations in Children: A Five-Year Follow-Up Study.
    Santos AN; Rauschenbach L; Saban D; Chen B; Herten A; Dinger TF; Li Y; Tippelt S; Della Marina A; Dohna-Schwake C; Schmidt B; Jabbarli R; Wrede KH; Sure U; Dammann P
    Stroke; 2022 Mar; 53(3):817-824. PubMed ID: 34706565
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Morbidity After Symptomatic Hemorrhage of Cerebral Cavernous Malformation: A Nomogram Approach to Risk Assessment.
    Ma L; Zhang S; Li Z; Wu CX; Wang Z; Zhan L; Hao Q; Wang H; Ye X; Chen X; Liu YO; Wang S; Zhao YL
    Stroke; 2020 Oct; 51(10):2997-3006. PubMed ID: 32951540
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association Between Beta-Blocker or Statin Drug Use and the Risk of Hemorrhage From Cerebral Cavernous Malformations.
    Zuurbier SM; Hickman CR; Rinkel LA; Berg R; Sure U; Al-Shahi Salman R;
    Stroke; 2022 Aug; 53(8):2521-2527. PubMed ID: 35410492
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Female Hormone Therapy and Risk of Intracranial Hemorrhage From Cerebral Cavernous Malformations: A Multicenter Observational Cohort Study.
    Zuurbier SM; Santos AN; Flemming KD; Schmidt B; Jabbarli R; Lanzino G; Sure U; Dammann P
    Neurology; 2023 Apr; 100(16):e1673-e1679. PubMed ID: 36754635
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Functional outcome after initial and multiple intracerebral hemorrhages in children with cerebral cavernous malformations.
    Santos AN; Rauschenbach L; Gull HH; Dinger TF; Chihi M; Li Y; Tippelt S; Dohna-Schwake C; Schmidt B; Jabbarli R; Wrede KH; Sure U; Dammann P
    Eur J Neurol; 2023 May; 30(5):1364-1370. PubMed ID: 36789485
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Solitary Sporadic Cerebral Cavernous Malformations: Risk Factors of First or Recurrent Symptomatic Hemorrhage and Associated Functional Impairment.
    Dammann P; Jabbarli R; Wittek P; Oppong MD; Kneist A; Zhu Y; Wrede K; Müller O; Forsting M; Sure U
    World Neurosurg; 2016 Jul; 91():73-80. PubMed ID: 27058610
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Natural history of brainstem cavernous malformations: prospective hemorrhage rate and adverse factors in a consecutive prospective cohort.
    Li D; Wu ZY; Liu PP; Ma JP; Huo XL; Wang L; Zhang LW; Wu Z; Zhang JT
    J Neurosurg; 2020 Mar; 134(3):917-928. PubMed ID: 32168479
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment of cerebral cavernous malformations: a systematic review and meta-regression analysis.
    Poorthuis MH; Klijn CJ; Algra A; Rinkel GJ; Al-Shahi Salman R
    J Neurol Neurosurg Psychiatry; 2014 Dec; 85(12):1319-23. PubMed ID: 24667206
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Predictors of future haemorrhage from cerebral cavernous malformations: a retrospective cohort study.
    Gillespie CS; Alnaham KE; Richardson GE; Mustafa MA; Taweel BA; Islim AI; Hannan CJ; Chavredakis E
    Neurosurg Rev; 2023 Feb; 46(1):52. PubMed ID: 36763222
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Multiple cerebral cavernous malformations: Clinical course of confirmed, assumed and non-familial disease.
    Santos AN; Rauschenbach L; Saban D; Chen B; Darkwah Oppong M; Herten A; Gull HH; Rieß C; Deuschl C; Schmidt B; Jabbarli R; Wrede KH; Zhu Y; Frank B; Sure U; Dammann P
    Eur J Neurol; 2022 May; 29(5):1427-1434. PubMed ID: 35060255
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.